<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02607605</url>
  </required_header>
  <id_info>
    <org_study_id>201507004</org_study_id>
    <nct_id>NCT02607605</nct_id>
  </id_info>
  <brief_title>A Prospective, Observational Trial on the Diagnostic and Prognostic of LM</brief_title>
  <acronym>ctDNA</acronym>
  <official_title>A Prospective, Observational Trial on the Diagnostic and Prognostic Value of Cell-free DNA in Advanced Lung Cancer With Leptomeningeal Metastases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to compare the positive rate between the cell-free DNA&#xD;
      and cytological examination of cerebrospinal fluid in Advanced lung cancer with&#xD;
      leptomeningeal metastases.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>positive rate between the cell-free DNA and cytological examination of cerebrospinal fluid</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The relationship between the number of cell-free DNA and OS</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Lung Neoplasms</condition>
  <condition>Meningeal Carcinomatosis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      patient's cerebrospinal fluid&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Clinical symptoms and imaging tests are highly suspicious of advanced lung cancer with&#xD;
        leptomeningeal metastases&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient who was confirmed primary lung cancer by pathologic histology or cytology&#xD;
&#xD;
          2. Adult patients (≥18 years and ≤75 years). ECOG Performance Status 0 or 1.Life&#xD;
             expectancy of at least 12 weeks.&#xD;
&#xD;
          3. Clinical symptoms and imaging tests are highly suspicious of advanced lung cancer with&#xD;
             leptomeningeal metastases&#xD;
&#xD;
          4. Without contraindications to lumbar puncture&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who have primary benign or malignant brain tumor and metastatic malignant&#xD;
             brain tumor&#xD;
&#xD;
          2. Patients who have contraindications to lumbar puncture&#xD;
&#xD;
          3. Serious uncontrolled systemic disease including active infection,uncontrolled&#xD;
             hypertension,diabetes,unstable angina,congestive heart failure,myocardial&#xD;
             infarction,severe arrhythmia which needs drugs,hepatic、renal and metabolic disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>li-kun Chen, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>li-kun chen, Doctor</last_name>
    <phone>13798019964</phone>
    <email>chenlk@sysucc.org.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sun Yat-sen University of cancer center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>li-kun chen, doctor</last_name>
      <phone>13798019964</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Pan W, Gu W, Nagpal S, Gephart MH, Quake SR. Brain tumor mutations detected in cerebral spinal fluid. Clin Chem. 2015 Mar;61(3):514-22. doi: 10.1373/clinchem.2014.235457. Epub 2015 Jan 20.</citation>
    <PMID>25605683</PMID>
  </results_reference>
  <results_reference>
    <citation>Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW Jr, Alizadeh AA, Diehn M. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med. 2014 May;20(5):548-54. doi: 10.1038/nm.3519. Epub 2014 Apr 6.</citation>
    <PMID>24705333</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>November 16, 2015</study_first_submitted>
  <study_first_submitted_qc>November 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2015</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Li-kun Chen</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>lung cancer</keyword>
  <keyword>leptomeningeal metastases</keyword>
  <keyword>cell-free DNA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Meningeal Carcinomatosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

